Skip to Main Content

Author Details

Dorothea Fiedler
Leibniz Forschungsinstitut fur Molekulare Pharmakologie (FMP)
2003
54
30
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36166450Chemoselective Labeling and Immobilization of Phosphopeptides with Phosphorimidazolide Reagents.Chembiochem2023
36166450Chemoselective Labeling and Immobilization of Phosphopeptides with Phosphorimidazolide Reagents.Chembiochem2023
37189392One Scaffold, Two Conformations: The Ring-Flip of the Messenger InsP<sub>8</sub> Occurs under Cytosolic Conditions.Biomolecules2023
37189392One Scaffold, Two Conformations: The Ring-Flip of the Messenger InsP<sub>8</sub> Occurs under Cytosolic Conditions.Biomolecules2023
34782304The inositol pyrophosphate metabolism of Dictyostelium discoideum does not regulate inorganic polyphosphate (polyP) synthesis.Adv Biol Regul2022
34782304The inositol pyrophosphate metabolism of Dictyostelium discoideum does not regulate inorganic polyphosphate (polyP) synthesis.Adv Biol Regul2022
33354791Affinity-based proteomics reveals novel targets of inositol pyrophosphate (5-IP<sub>7</sub> )-dependent phosphorylation and binding in Trypanosoma cruzi replicative stages.Mol Microbiol2021
33860201Identification of Small-Molecule Inhibitors of Human Inositol Hexakisphosphate Kinases by High-Throughput Screening.ACS Pharmacol Transl Sci2021
33475202New structural insights reveal an expanded reaction cycle for inositol pyrophosphate hydrolysis by human DIPP1.FASEB J2021
34274522ITPK1 is an InsP<sub>6</sub>/ADP phosphotransferase that controls phosphate signaling in Arabidopsis.Mol Plant2021
33354791Affinity-based proteomics reveals novel targets of inositol pyrophosphate (5-IP<sub>7</sub> )-dependent phosphorylation and binding in Trypanosoma cruzi replicative stages.Mol Microbiol2021
33860201Identification of Small-Molecule Inhibitors of Human Inositol Hexakisphosphate Kinases by High-Throughput Screening.ACS Pharmacol Transl Sci2021
34274522ITPK1 is an InsP<sub>6</sub>/ADP phosphotransferase that controls phosphate signaling in Arabidopsis.Mol Plant2021
33475202New structural insights reveal an expanded reaction cycle for inositol pyrophosphate hydrolysis by human DIPP1.FASEB J2021
32783964Triplexed Affinity Reagents to Sample the Mammalian Inositol Pyrophosphate Interactome.Cell Chem Biol2020
32019887Control of XPR1-dependent cellular phosphate efflux by InsP<sub>8</sub> is an exemplar for functionally-exclusive inositol pyrophosphate signaling.Proc Natl Acad Sci U S A2020
32822581Inositol Pyrophosphates Mediate the DNA-PK/ATM-p53 Cell Death Pathway by Regulating CK2 Phosphorylation of Tti1/Tel2.Mol Cell2020
33247133Analysis of inositol phosphate metabolism by capillary electrophoresis electrospray ionization mass spectrometry.Nat Commun2020
33115740The inositol pyrophosphate 5-InsP<sub>7</sub> drives sodium-potassium pump degradation by relieving an autoinhibitory domain of PI3K p85α.Sci Adv2020
32783964Triplexed Affinity Reagents to Sample the Mammalian Inositol Pyrophosphate Interactome.Cell Chem Biol2020
32019887Control of XPR1-dependent cellular phosphate efflux by InsP<sub>8</sub> is an exemplar for functionally-exclusive inositol pyrophosphate signaling.Proc Natl Acad Sci U S A2020
33115740The inositol pyrophosphate 5-InsP<sub>7</sub> drives sodium-potassium pump degradation by relieving an autoinhibitory domain of PI3K p85α.Sci Adv2020
33247133Analysis of inositol phosphate metabolism by capillary electrophoresis electrospray ionization mass spectrometry.Nat Commun2020
32822581Inositol Pyrophosphates Mediate the DNA-PK/ATM-p53 Cell Death Pathway by Regulating CK2 Phosphorylation of Tti1/Tel2.Mol Cell2020
31111417Electron Transfer/Higher Energy Collisional Dissociation of Doubly Charged Peptide Ions: Identification of Labile Protein Phosphorylations.J Am Soc Mass Spectrom2019
31111417Electron Transfer/Higher Energy Collisional Dissociation of Doubly Charged Peptide Ions: Identification of Labile Protein Phosphorylations.J Am Soc Mass Spectrom2019
29443975Features and regulation of non-enzymatic post-translational modifications.Nat Chem Biol2018
29883610MLKL Requires the Inositol Phosphate Code to Execute Necroptosis.Mol Cell2018
29443975Features and regulation of non-enzymatic post-translational modifications.Nat Chem Biol2018
29883610MLKL Requires the Inositol Phosphate Code to Execute Necroptosis.Mol Cell2018
26760216A Stable Pyrophosphoserine Analog for Incorporation into Peptides and Proteins.ACS Chem Biol2016
26760216A Stable Pyrophosphoserine Analog for Incorporation into Peptides and Proteins.ACS Chem Biol2016
26828065A Novel Inositol Pyrophosphate Phosphatase in Saccharomyces cerevisiae: Siw14 PROTEIN SELECTIVELY CLEAVES THE β-PHOSPHATE FROM 5-DIPHOSPHOINOSITOL PENTAKISPHOSPHATE (5PP-IP5).J Biol Chem2016
27474409Inositol hexakisphosphate kinase 1 (IP6K1) activity is required for cytoplasmic dynein-driven transport.Biochem J2016
27462803Chemical tools for interrogating inositol pyrophosphate structure and function.Chem Soc Rev2016
27460418Cellular Cations Control Conformational Switching of Inositol Pyrophosphate Analogues.Chemistry2016
27791083Inositol polyphosphates intersect with signaling and metabolic networks via two distinct mechanisms.Proc Natl Acad Sci U S A2016
27791083Inositol polyphosphates intersect with signaling and metabolic networks via two distinct mechanisms.Proc Natl Acad Sci U S A2016
27474409Inositol hexakisphosphate kinase 1 (IP6K1) activity is required for cytoplasmic dynein-driven transport.Biochem J2016
27462803Chemical tools for interrogating inositol pyrophosphate structure and function.Chem Soc Rev2016
27460418Cellular Cations Control Conformational Switching of Inositol Pyrophosphate Analogues.Chemistry2016
26828065A Novel Inositol Pyrophosphate Phosphatase in Saccharomyces cerevisiae: Siw14 PROTEIN SELECTIVELY CLEAVES THE β-PHOSPHATE FROM 5-DIPHOSPHOINOSITOL PENTAKISPHOSPHATE (5PP-IP5).J Biol Chem2016
25639821Establishing the stability and reversibility of protein pyrophosphorylation with synthetic peptides.Chembiochem2015
25888283Differential genetic interactions of yeast stress response MAPK pathways.Mol Syst Biol2015
25651128An affinity reagent for the recognition of pyrophosphorylated peptides.Angew Chem Int Ed Engl2015
25639821Establishing the stability and reversibility of protein pyrophosphorylation with synthetic peptides.Chembiochem2015
26061479A Fluorescent Sensor and Gel Stain for Detection of Pyrophosphorylated Proteins.ACS Chem Biol2015
26061479A Fluorescent Sensor and Gel Stain for Detection of Pyrophosphorylated Proteins.ACS Chem Biol2015
25888283Differential genetic interactions of yeast stress response MAPK pathways.Mol Syst Biol2015
25651128An affinity reagent for the recognition of pyrophosphorylated peptides.Angew Chem Int Ed Engl2015
  • 1 - 50 of 108

Recommended Authors

Timothy S Strutzenberg
Salk Institute for Biological Studies
Career Start Year 2014
Number of shared co-authors 0
Zhi Lin
Shanghai Jiao Tong University
Career Start Year 2012
Number of shared co-authors 0
Daniel Carbajo
Institut de Quimica Avancada de Catalunya (IQAC-CSIC)
Career Start Year 2011
Number of shared co-authors 0
Amit Choudhary
Broad Institute of MIT and Harvard
Career Start Year 2009
Number of shared co-authors 0
Nir London
The Weizmann Institute of Science
Career Start Year 2007
Number of shared co-authors 1
Lisa M Miller Jenkins
National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 0
Farid El Oualid
The Netherlands Cancer Institute
Career Start Year 2004
Number of shared co-authors 4
Luke L Lairson
The Scripps Research Institute
Career Start Year 2003
Number of shared co-authors 1
Ronald D Seidel
Albert Einstein College of Medicine
Career Start Year 2001
Number of shared co-authors 0
Milka Kostic
Dana-Farber Cancer Institute .
Career Start Year 2001
Number of shared co-authors 1
Jason E Gestwicki
Institute for Neurodegenerative Diseases, University of California San Francisco
Career Start Year 2000
Number of shared co-authors 5
Haibin Mao
University of Washington Howard Hughes Medical Institute, University of Washington
Career Start Year 1999
Number of shared co-authors 0
Jeffrey B Bonanno
Albert Einstein College of Medicine
Career Start Year 1999
Number of shared co-authors 0
Feixia Chu
University of New Hampshire
Career Start Year 1999
Number of shared co-authors 5
Fei Liu
Macquarie University
Career Start Year 1998
Number of shared co-authors 0
Jack Taunton
University of California san francisco
Career Start Year 1996
Number of shared co-authors 7
Abhinav Kumar
University of Lucknow
Career Start Year 1996
Number of shared co-authors 0
Paul J Hergenrother
University of Illinois at Urbana-Champaign
Career Start Year 1995
Number of shared co-authors 2
Fabio C Gozzo
Institute of Chemistry, University of Campinas
Career Start Year 1995
Number of shared co-authors 1
Tom W Muir
Princeton University
Career Start Year 1993
Number of shared co-authors 4
Eduard Sergienko
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1992
Number of shared co-authors 0
Philip A Cole
Brigham and Women's Hospital, Blavatnik Institute, Harvard Medical School
Career Start Year 1990
Number of shared co-authors 3
Andreas Hofmann
Heidelberg University
Career Start Year 1989
Number of shared co-authors 1
Sally Freeman
Division of Pharmacy and Optometry, University of Manchester
Career Start Year 1988
Number of shared co-authors 0
Yi-Liang Liu
National Chung Hsing University
Career Start Year 1988
Number of shared co-authors 1
Laura L Kiessling
Massachusetts Institute of Technology
Career Start Year 1987
Number of shared co-authors 2
Stuart L Schreiber
Broad Institute
Career Start Year 1985
Number of shared co-authors 5
David S Lawrence
University of North Carolina
Career Start Year 1984
Number of shared co-authors 0
Stefan Knapp
Institute of Pharmaceutical Chemistry, Goethe University
Career Start Year 1983
Number of shared co-authors 2
Ronald T Raines
Massachusetts Institute of Technology
Career Start Year 1981
Number of shared co-authors 1

Collaborators

Kevan M Shokat
University of California San Francisco
Co-authored papers 11
Mingxuan Wu
Co-authored papers 8
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 7
Henning J Jessen
Co-authored papers 7
Michael Shales
University of California, USA Quantitative Biosciences Institute (QBI) san francisco
Co-authored papers 5
Adam C Resnick
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Co-authored papers 3
Chenglai Fu
Co-authored papers 3
Adolfo Saiardi
Co-authored papers 3
Solomon H Snyder
Co-authored papers 3
Lucy S Chong
Co-authored papers 3
Wendell A Lim
University of California san francisco
Co-authored papers 2
Pedro Beltrao
Institute of Molecular Systems Biology, ETH Zurich
Co-authored papers 2
Michael-Christopher Keogh
EpiCypher Inc.
Co-authored papers 2
Sake van Wageningen
Oncode Institute, The Netherlands Cancer Institute
Co-authored papers 2
Patrick Kemmeren
Princess Maxima Center for Pediatric Oncology
Co-authored papers 2
Frank C P Holstege
Princess Maxima Center for Pediatric Oncology
Co-authored papers 2
Risheng Xu
Co-authored papers 2
Daphne Koller
Stanford University
Co-authored papers 2
Michael A Koldobskiy
Co-authored papers 2
Roxanne K Barrow
Co-authored papers 2
Richa Tyagi
Co-authored papers 2
Sean R Collins
University of California davis
Co-authored papers 2
Monika Mehta
Albert Einstein College of Medicine
Co-authored papers 2
Wilbert B Copeland
University of Washington
Co-authored papers 1
Marc Ferrer
National Institutes of Health, National Center for Advancing Translational Sciences
Co-authored papers 1
Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Co-authored papers 1
Nathalie Brabers
University Medical Centre Utrecht, Universiteitsweg
Co-authored papers 1
Aude Gu??nol??
CNRS, Universite de Toulouse
Co-authored papers 1
Philip Lijnzaad
Princess Maxima Center for Pediatric Oncology
Co-authored papers 1
Cheuk W Ko
University Medical Centre Utrecht, Universiteitsweg
Co-authored papers 1
Release 1.2